(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modeling study ...

Wastewater samples have shown elevated levels of a respiratory virus that has been linked to paralysis in some children, ...

Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

During clinical trials, researchers observed higher-than-expected rates of Guillain-Barré syndrome, a disorder in which the ...

Officials suggest the respiratory syncytial ... illness from the virus, as are premature infants, older adults and people with heart and lung disease or a weak immune system.

The recent surge in COVID-19 infections nationwide is a reminder: It’s not too early to start thinking about fall booster shots. Driven in large part by the arrival of a new family of variants ...

The following is a summary of “Respiratory viral infections from 2015 to 2022 in the HIVE cohort of American households: Incidence, illness characteristics, and seasonality,” published in the August ...

RSV, or respiratory syncytial virus ... If the virus moves into the lungs, it can cause coughing and wheezing, and turn into a severe respiratory disease, such as bronchiolitis – inflammation ...

Respiratory syncytial virus (RSV) infections are the leading ... RSV also causes bronchiolitis, pneumonia and chronic obstructive pulmonary disease (COPD) exacerbations in the elderly, which ...